TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8301153

Group type: EXPERIMENTAL
Intervention: 0.8 million units (mU) of Betaseron
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4 million units (mU) of Betaseron
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 8 million units (mU) of Betaseron
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 16 million units (mU) of Betaseron
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (WHO Standard)
Number of subjects: 30
Study: 3510847

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg once daily
Number of subjects: 178

Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 178

Group type: COMPARATOR
Intervention: Ranitidine
Number of subjects: 178
Study: 2646187

Group type: EXPERIMENTAL
Intervention: Intravaginal application of tablets containing 3 mg of prostaglandin E2
Number of subjects: 345

Group type: COMPARATOR
Intervention: Spontaneous onset of labor awaited until the 42nd week of pregnancy
Number of subjects: 345
Study: 31882375

Group type: EXPERIMENTAL
Intervention: Apolipoprotein B (apo B) levels
Number of subjects: 4623

Group type: EXPERIMENTAL
Intervention: Apo B discordance relative to LDL-C
Number of subjects: 4623

Group type: EXPERIMENTAL
Intervention: Apo B discordance relative to non-HDL-C
Number of subjects: 4623

Group type: EXPERIMENTAL
Intervention: Apo B
Number of subjects: 4623
Study: 29902969

Group type: EXPERIMENTAL
Intervention: BIS-guided propofol administration (target range 40-60)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Weight-related propofol administration (2 mg/kg)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: BIS-guided propofol administration
Number of subjects: 240

Group type: COMPARATOR
Intervention: Weight-related propofol administration
Number of subjects: 240
Study: 28260153

Group type: EXPERIMENTAL
Intervention: Tourniquet used from the beginning of osteotomy to the completion of arthroplasty (Group C)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tourniquet used from the beginning of operation to the completion of joint replacement (Group B)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tourniquet used during the entire operation (Group A)
Number of subjects: 150
Study: 26287881

Group type: EXPERIMENTAL
Intervention: LASIK with concurrent high-fluence CXL
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard LASIK (LASIK-only)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Comparison of LASIK-CXL and LASIK-only
Number of subjects: 140
Study: 23442755

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 154

Group type: COMPARATOR
Intervention: Low-dose progestin treatment (2.5 mg/day norethisterone acetate)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Low-dose progestin treatment
Number of subjects: 154
Study: 21394001

Group type: EXPERIMENTAL
Intervention: Basal infusion of 0.1% ropivacaine (5 ml/h for 6 hours)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Repeated hourly bolus doses of 0.1% ropivacaine
Number of subjects: 11

Group type: COMPARATOR
Intervention: Basal infusion vs. bolus doses comparison
Number of subjects: 11
Study: 18349213

Group type: EXPERIMENTAL
Intervention: i.v. granisetron 1 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 40
Study: 16531384

Group type: EXPERIMENTAL
Intervention: Compression-only CPR (COCPR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional CPR (TCPR)
Number of subjects: 50
Study: 14711749

Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy
Number of subjects: 1380
Study: 11152365

Group type: EXPERIMENTAL
Intervention: Surgery for unruptured aneurysms
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Surgery for Grade 1 to 3 subarachnoid hemorrhage
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Surgery for Grade 4 or 5 subarachnoid hemorrhage
Number of subjects: 79
Study: 9418686

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) 50 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: No ovulation‐induction drugs (spontaneous group)
Number of subjects: 33
Study: 7516915

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide 4 g/m2 plus G-CSF (5 or 10 micrograms/kg)
Number of subjects: 9
Study: 2963647

Group type: EXPERIMENTAL
Intervention: Mobilat ointment (active treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 30317947

Group type: EXPERIMENTAL
Intervention: Yogurt with β-glucans from Ganoderma lucidum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25758041

Group type: EXPERIMENTAL
Intervention: Legume-enriched diet
Number of subjects: 26

Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 26
Study: 23928749

Group type: EXPERIMENTAL
Intervention: In control: No alcohol! intervention
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 213
Study: 22205355

Group type: EXPERIMENTAL
Intervention: Combined treatment with an angiotensin-converting inhibitor and receptor blocker
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Inhibitor alone
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Inhibitor-blocker treatment
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Gender differences
Number of subjects: 1044

Group type: EXPERIMENTAL
Intervention: Anthropomorphic measures
Number of subjects: 1044
Study: 20452823

Group type: EXPERIMENTAL
Intervention: Pramipexole (0.125-1.0 mg three times per day)
Number of subjects: 287

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study: 18665164

Group type: EXPERIMENTAL
Intervention: Capecitabine 1250 mg m(‐2) two times daily on days 1‐14 every 3 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: S-1 40‐60 mg two times daily according to body surface area on days 1‐28 every 6 weeks
Number of subjects: 96
Study: 15567880

Group type: EXPERIMENTAL
Intervention: GnRH antagonist (2 mg/2 ml, 1 mg/ml, 0.5 mg/ml, 0.5 mg/0.5 ml or 0.25 mg/ml)
Number of subjects: 144
Study: 12759654

Group type: EXPERIMENTAL
Intervention: Low dose multidetector CT (30 mA protocol)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low dose multidetector CT (10 mA protocol)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard two view chest examination
Number of subjects: 10
Study: 10760555

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 10706

Group type: COMPARATOR
Intervention: Tricyclic antidepressants (TCAs)
Number of subjects: 10706

Group type: COMPARATOR
Intervention: Amitriptyline (TCA)
Number of subjects: 10706

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (SSRI)
Number of subjects: 10706

Group type: COMPARATOR
Intervention: Dothiepin (TCA)
Number of subjects: 10706
Study: 9233976

Group type: COMPARATOR
Intervention: Diet (D)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Exercise (E)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 36
Study: 8392032

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite-coated bipolar hemiarthroplasty
Number of subjects: 82

Group type: COMPARATOR
Intervention: Uncemented bipolar prosthesis
Number of subjects: 82
Study: 3526155

Group type: EXPERIMENTAL
Intervention: Ceftazidime alone
Number of subjects: 550

Group type: COMPARATOR
Intervention: Combination therapy (cephalothin, gentamicin, and carbenicillin)
Number of subjects: 550
Study: 31907104

Group type: EXPERIMENTAL
Intervention: Escitalopram (E)
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Medical treatment only (M)
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Screening positive (S)
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Screening negative (N)
Number of subjects: 1152
Study: 31050078

Group type: EXPERIMENTAL
Intervention: 3-day antibiotic treatment
Number of subjects: 33745

Group type: COMPARATOR
Intervention: 7-day antibiotic treatment
Number of subjects: 33745
Study: 28681388

Group type: EXPERIMENTAL
Intervention: Natalizumab (NTZ) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (NTZ-ctr)
Number of subjects: 0
Study: 24931061

Group type: EXPERIMENTAL
Intervention: One MetS-like component
Number of subjects: 6426

Group type: EXPERIMENTAL
Intervention: Two MetS-like components
Number of subjects: 6426

Group type: EXPERIMENTAL
Intervention: Three to four MetS-like components
Number of subjects: 6426
Study: 22733406

Group type: EXPERIMENTAL
Intervention: Intravascular low-energy laser irradiation (λ=808 nm) during PCI
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no laser irradiation)
Number of subjects: 101
Study: 21316267

Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV) 1000 mg/day
Number of subjects: 31

Group type: COMPARATOR
Intervention: Carbamazepine-CR (CBZ-CR) 400 mg/day
Number of subjects: 31
Study: 19168111

Group type: EXPERIMENTAL
Intervention: PncCRM vaccine
Number of subjects: 1662

Group type: COMPARATOR
Intervention: Control vaccine
Number of subjects: 1662
Study: 16889453

Group type: EXPERIMENTAL
Intervention: Quetiapine (200-800 mg/day)
Number of subjects: 673

Group type: COMPARATOR
Intervention: Risperidone (2-8 mg/day)
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 673

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 673
Study: 14770380

Group type: EXPERIMENTAL
Intervention: isopropyl alcohol
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: oil of peppermint
Number of subjects: 33

Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: overall satisfaction with postoperative nausea management
Number of subjects: 33
Study: 11526664

Group type: EXPERIMENTAL
Intervention: Three different programs for drunken driving offenders
Number of subjects: 912
Study: 9683300

Group type: EXPERIMENTAL
Intervention: oral clodronate 1600 mg daily for 3 years
Number of subjects: 206

Group type: COMPARATOR
Intervention: control group (no clodronate)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: changes in PINP levels at 12 months
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: changes in PINP and BMD
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: ICTP and BMD changes
Number of subjects: 206
Study: 7831070

Group type: EXPERIMENTAL
Intervention: Penile vibratory stimulation (PVS) with a frequency of 100 Hz and peak-to-peak amplitude of 1 mm
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Penile vibratory stimulation (PVS) with a frequency of 100 Hz and peak-to-peak amplitude of 2.5 mm
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Penile vibratory stimulation (PVS) with a frequency of 100 Hz and peak-to-peak amplitude of 2.5 mm in population II
Number of subjects: 66
Study: 2962321

Group type: EXPERIMENTAL
Intervention: Heparin 5,000 International units per liter added to warm isotonic Ringer's lactate solution
Number of subjects: 92

Group type: COMPARATOR
Intervention: No heparin added to warm isotonic Ringer's lactate solution
Number of subjects: 92
Study: 31764194

Group type: EXPERIMENTAL
Intervention: Real-time Effort Driven ventilator management (REDvent)
Number of subjects: 0
Study: 30586732

Group type: EXPERIMENTAL
Intervention: mWellcare (mHealth system with electronic health record storage and electronic decision support)
Number of subjects: 3698

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 3698

Group type: EXPERIMENTAL
Intervention: mWellcare
Number of subjects: 3698
Study: 28430340

Group type: EXPERIMENTAL
Intervention: Endoscopic intracorporeal lithotripsy in gas (СО2) medium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Contact ureterolithotripsy in 0.9% NaCL medium (Control)
Number of subjects: 60
Study: 25488181

Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral intervention involving contact with the target group
Number of subjects: 18

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 18
Study: 23761104

Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose infusion of 30 g/150 mL water plus 3 g 3‐O‐methylglucose (3‐OMG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose infusion of 30 g/150 mL water plus 3 g 3‐OMG
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy subjects during hyperglycemia
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Type 2 diabetic patients during acute hyperglycemia
Number of subjects: 27
Study: 22164503

Group type: EXPERIMENTAL
Intervention: Anluo Huaxian Wan
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine liver protection drugs
Number of subjects: 120
Study: 19407949

Group type: EXPERIMENTAL
Intervention: Auricular points sticking-pressing (APSP), pellets pressed 4 times daily
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (lactation to meet infant demand)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Auricular points sticking-pressing (APSP)
Number of subjects: 116
Study: 17083414

Group type: EXPERIMENTAL
Intervention: PALSA intervention training program for nurse trainers
Number of subjects: 0
Study: 15241828

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by radiotherapy
Number of subjects: 286

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 286
Study: 11250623

Group type: EXPERIMENTAL
Intervention: Wire osteosynthesis with 8 weeks of maxillomandibular fixation
Number of subjects: 127

Group type: COMPARATOR
Intervention: Rigid internal fixation
Number of subjects: 127
Study: 9431616

Group type: EXPERIMENTAL
Intervention: Segmental transpedicular instrumentation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Noninstrumented group
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Overall successful fusion
Number of subjects: 76
Study: 7781464

Group type: EXPERIMENTAL
Intervention: Atropine (7 micrograms/kg) during active gas infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo during active gas infusion
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sham gas administration
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Active gas infusion
Number of subjects: 20
Study: 2146577

Group type: EXPERIMENTAL
Intervention: Ondansetron 3 x 8 mg/day for a maximum of 10 cycles
Number of subjects: 40
Study: 356241

Group type: EXPERIMENTAL
Intervention: Proquazone (900 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Indomethacin (75 mg daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Proquazone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 60
Study: 30129973

Group type: EXPERIMENTAL
Intervention: Inclusion of vitamin C-rich fruit in regular meals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 28527564

Group type: EXPERIMENTAL
Intervention: Peri- and postoperative antibiotic prophylaxis (POAP) from the day of operation until the fifth day postoperatively
Number of subjects: 75

Group type: COMPARATOR
Intervention: Perioperative antibiotic prophylaxis (PEAP) only
Number of subjects: 75

Group type: COMPARATOR
Intervention: Perioperative antibiotic prophylaxis and increased local antiseptic care (PAPAC)
Number of subjects: 75
Study: 24350597

Group type: EXPERIMENTAL
Intervention: Moderate-dose endurance training (MOD, 300 kcal/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High-dose endurance training (HIGH, 600 kcal/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 50
Study: 24118700

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Levobupivacaine
Number of subjects: 60
Study: 22938147

Group type: EXPERIMENTAL
Intervention: Extraction of pulpally involved primary teeth (Group A)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Untreated children (Group B)
Number of subjects: 164
Study: 20455886

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (60,000 IU D3/week for 8 weeks followed by 60,000 IU/month for 4 months) with 1 g of elemental calcium daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dual placebos
Number of subjects: 40
Study: 16575494

Group type: EXPERIMENTAL
Intervention: Calcitonin (100 IU salmon calcitonin)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16239760

Group type: EXPERIMENTAL
Intervention: Olanzapine (exact dosage and duration not specified)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 11872681

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 10463251

Group type: EXPERIMENTAL
Intervention: Iprazochrome 15 mg daily in three equal doses for eight weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 9017568

Group type: EXPERIMENTAL
Intervention: Methadone treatment
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Continuation of treatment on a fee-for-service basis
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Transfer to another treatment provider
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Detoxification
Number of subjects: 500
Study: 1984613

Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (BSS)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 6685516

Group type: EXPERIMENTAL
Intervention: Piretanide 12 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Furosemide 80 mg
Number of subjects: 12
Study: 31172819

Group type: EXPERIMENTAL
Intervention: FriWalk robotic walker
Number of subjects: 42
Study: 31623597

Group type: EXPERIMENTAL
Intervention: Mindfulness-based mental health prevention program
Number of subjects: 1166

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1166
Study: 28363894

Group type: EXPERIMENTAL
Intervention: Short stem femoral component
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional stem femoral component
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 86
Study: 25222799

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (Coping Cat) for 12 weeks
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Medication (sertraline) for 12 weeks
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Combination of cognitive-behavioral treatment and medication for 12 weeks
Number of subjects: 488

Group type: COMPARATOR
Intervention: Pill placebo for 12 weeks
Number of subjects: 488
Study: 23916715

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait list condition
Number of subjects: 0
Study: 21105964

Group type: EXPERIMENTAL
Intervention: Wrap with polyethylene plastic sheets
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (dried with warmed towels under a warmer)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Wrap with polyethylene plastic sheets (among infants <28 weeks' gestation)
Number of subjects: 110
Study: 19052049

Group type: EXPERIMENTAL
Intervention: Detailed risk information
Number of subjects: 122

Group type: COMPARATOR
Intervention: Simple risk information
Number of subjects: 122
Study: 16501038

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg, twice daily)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 16529161

Group type: EXPERIMENTAL
Intervention: Renal replacement therapy (haemodialysis) with polysulphone membranes
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Renal transplantation
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Higher BMI values
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Efficiency of dialysotherapy and ultrafiltration
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Pre-transplantation pentosidine concentration
Number of subjects: 67
Study: 11387733

Group type: EXPERIMENTAL
Intervention: Clinician-Administered PTSD Scale (CAPS)
Number of subjects: 200
Study: 1315650

Group type: EXPERIMENTAL
Intervention: Angiotensin II (10 ng min‐1 kg‐1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Angiotensin II (3 ng min‐1 kg‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (5% D-glucose)
Number of subjects: 8
Study: 3914313

Group type: EXPERIMENTAL
Intervention: diastolic blood pressure biofeedback
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: progressive deep muscle relaxation training
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: self‐directed relaxation training
Number of subjects: 52

Group type: COMPARATOR
Intervention: medication alone
Number of subjects: 52
Study: 31960341

Group type: EXPERIMENTAL
Intervention: Social networks influence on weight gain and weight loss; specific intervention details not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stochastic actor‐oriented modeling; specific intervention details not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natural experiment or randomized designs; specific intervention details not available.
Number of subjects: 0
Study: 30009223

Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg ketamine
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg ketamine
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 26787177

Group type: EXPERIMENTAL
Intervention: Robotic cystectomy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Open cystectomy
Number of subjects: 10
Study: 24508795

Group type: EXPERIMENTAL
Intervention: Cross-linking once (Group A)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cross-linking twice (Group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cross-linking three times (Group C)
Number of subjects: 30

Group type: COMPARATOR
Intervention: All treated groups (A, B, C)
Number of subjects: 30
Study: 22560677

Group type: EXPERIMENTAL
Intervention: Tobacco dependence measures
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Motivation to quit smoking measures
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intention to quit smoking
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Social environmental factors
Number of subjects: 60